NanoAssemblr commercial formulation system: Clinical and commercial production of lipid nanoparticle 

The NanoAssemblr commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles under cgmp conditions.
Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.
The system enables standardized manufacturing workflows through scalable single-use technology, built-in automation, regulatory-compliant software and materials traceability.
Contact us today to request a quote or learn more at www.cytiva.com/

Наука